Items Tagged ‘GP2’

September 16th, 2014

Vaccine Derived from HER2 Protein May Help Prevent Breast Cancer Recurrence


A new breast cancer vaccine that is derived from the HER2 protein may help prevent recurrence in patients with HER2-positive disease and appears safe. Phase II study results of the vaccine were released at the 2014 Breast Cancer Symposium, September 4–6, in San Francisco. The HER2 protein, also known as human epidermal growth factor receptor 2, […]

View full entry

Tags: Breast Cancer, GP2, HER2, Metastatic Breast Cancer, News, Recurrent Breast Cancer, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer, vaccine